Comments on: AM-Pharma Begins Phase 2 Trial of Ilofotase Alfa For Renal Damage Prevention https://lifescivoice.com/am-pharma-begins-phase-2-trial-of-ilofotase-alfa-for-renal-damage-prevention/ Life Sciences Voice | The leading resource for life sciences industry executives. Mon, 22 Jan 2024 07:23:29 +0000 hourly 1 https://wordpress.org/?v=6.8.1